Euro falls against Canadian Dollar as surging oil prices overpower strong German data
EUR/CAD continues its losing streak for the third successive day, trading around 1.5920 during the European hours on Wednesday. The currency cross is under downward pressure as the Euro (EUR) faces headwinds despite a stronger-than-expected rebound in German industrial performance.
According to official statistics, German factory output surged 2% in September, easily beating forecasts of a 0.5% gain and reversing August's 1.2% contraction. On an annualized basis, industrial production rose 2.3%, recovering from a 1.6% decline in the previous month. However, these solid economic metrics have been overshadowed by a broader risk-averse market sentiment that continues to weigh on the Euro.
Rising geopolitical friction in the Middle East has pushed Brent crude back above $100 per barrel, rekindling fears of energy-driven inflation and slower growth across the Eurozone. Supply security remains precarious as Iran intensifies attacks on commercial vessels in the Strait of Hormuz, with UK Maritime Trade Operations citing nine incidents this month alone, and Saudi forces intercepting a Houthi ballistic missile targeting Khamis Mushait.
Compounding these supply risks, oil prices saw further gains on Wednesday as markets monitored a developing storm in the Gulf of Mexico, which forecasters warn could become the Atlantic's first hurricane of 2026 and threaten key US offshore energy infrastructure.
These surging crude prices have provided strong support for the commodity-linked Canadian Dollar (CAD) at the expense of the Euro. As persistent risks to global energy flows keep oil prices elevated, the resulting strength in the Canadian Dollar continues to drag the EUR/CAD cross lower.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-Caribou shares plunge as company explores sale and cancels cancer project
October 7 - ** Caribou Biosciences (CRBU.O) shares fell 35.9% in pre-market trading to $0.72 ** Caribou Biosciences announced late Tuesday that it is exploring strategic options, including a potential sale, merger, or other transactions, to maximize shareholder value ** Caribou said it plans to halt development of its allogeneic CAR-T cell therapy programs, including vispa-cel for non-Hodgkin lymphoma and CB-011 for multiple myeloma ** Caribou also stated it will lay off employees and cut costs, with most layoffs expected to be completed by Q4 2026 ** As of June 30, the company held $113.8 millions in cash, cash equivalents, and marketable securities ** As of the previous trading day's close, the company's share price had dropped about 28% year-to-date (Note: For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them only for reader convenience. Reuters assumes no responsibility for any damages or losses resulting from the use of automated translation features.)
Australian Dollar: Neutral outlook inside tight range against US Dollar – UOB
Power Root buys back shares for MYR 147,891.13
Power Root bought back 134,300 ordinary shares on Oct. 7, 2026, paying MYR 147,891.13. Purchases were priced between MYR 1.08 and MYR 1.12; all shares were retained as treasury stock. Treasury shares rose to 16,051,800, representing 3.78% of issued shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Power Root Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3712895) on October 07, 2026, and is solely responsible for the information contained therein.
EPF Board trims IOI Corp stake, disposes 800,000 shares; holding at 18.651%
Malaysia’s EPF cut its stake in IOI Corp via the disposal of 800,000 ordinary shares on Oct. 2, 2026. EPF’s direct holding stood at 1,172,249,528 shares, equal to 18.65% of issued shares, following the transaction. The disclosure was dated Oct. 5, 2026, with the company receiving the notice on Oct. 7, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IOI Corporation Berhad published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3712867) on October 07, 2026, and is solely responsible for the information contained therein.
